Medpace Holdings (MEDP) Net Cash Flow (2015 - 2026)

Medpace Holdings (MEDP) has 12 years of Net Cash Flow data on file, last reported at -$150.2 million in Q2 2026.

• Quarterly Net Cash Flow rose 62.26% year-over-year to -$150.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $457.4 million (up 197.56% YoY) and the FY2025 annual result came in at -$178.3 million, down 141.81% from the prior year.
• Net Cash Flow slipped to -$150.2 million in Q2 2026, from $157.7 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $239.0 million in Q3 2025 to a low of -$398.1 million in Q2 2025.
• A 5-year average of $2.5 million and a median of $16.2 million in 2023 frame the typical range for Net Cash Flow.
• Annual changes were most pronounced in 2022 — Net Cash Flow sank 764.14% — and 2023, when it soared 4199.56%.
• Tracing MEDP's Net Cash Flow over 5 years: stood at -$3.7 million in 2022, then soared by 4199.56% to $149.9 million in 2023, then sank by 90.33% to $14.5 million in 2024, then jumped by 1355.04% to $210.9 million in 2025, then tumbled by 171.22% to -$150.2 million in 2026.
• The last three Net Cash Flow figures came in at -$150.2 million (Q2 2026), $157.7 million (Q1 2026), and $210.9 million (Q4 2025), per Business Quant data.